Ikarian Capital’s Affimed AFMD Stock Holding History

Ikarian Capital’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,310	Closed	-$792K	–	213
2021 Q2	$792K	Buy	+9,310	New	+$849K	0.06%	167

Other funds holding AFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ikarian Capital's AFMD Position: Q3 2021 in Review

Ikarian Capital sold out of Affimed (AFMD) in Q3 2021, closing a stake of 9,310 shares — an estimated $792K sold.

Ikarian Capital first reported a position in AFMD in Q2 2021 and held it in 1 quarter. The position peaked at $792K in Q2 2021. 126 funds tracked by Wall St. Rank hold AFMD as of Q3 2021.

Ikarian Capital reported no remaining Affimed position as of Q3 2021 after selling out during the quarter.
Ikarian Capital sold 9,310 Affimed shares in Q3 2021, an estimated $792K.
Ikarian Capital first reported a position in Affimed in Q2 2021 and held it in 1 quarter.
Ikarian Capital's Affimed position peaked at $792K in Q2 2021.
126 funds tracked by Wall St. Rank held Affimed as of Q3 2021.

Based on Ikarian Capital's 13F filing for Q3 2021, filed 15 Nov 2021.